TWM
GSK icon

Tripletail Wealth Management’s GSK GSK Stock Holding History

Tripletail Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563K Sell
10,497
-645
-6% -$34.1K 0.65% 36
2026
Q1 		$632K Sell
11,142
-500
-4% -$27.1K 0.86% 28
2025
Q4 		$571K Hold
11,642
– – 0.72% 34
2025
Q3 		$503K Sell
11,642
-100
-0.9% -$3.91K 0.6% 34
2025
Q2 		$444K Buy
+11,742
New +$449K 0.63% 38

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tripletail Wealth Management's GSK Position: Q2 2026 in Review

Tripletail Wealth Management reduced its GSK (GSK) stake by 5.8% in Q2 2026, selling an estimated $34.1K and leaving 10,497 shares worth $563K. The position accounts for 0.65% of the portfolio, ranked #36.

Tripletail Wealth Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $632K in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Tripletail Wealth Management held 10,497 shares of GSK worth $563K as of Q2 2026.
  • Tripletail Wealth Management sold 645 GSK shares in Q2 2026, an estimated $34.1K.
  • GSK made up 0.65% of Tripletail Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Tripletail Wealth Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • Tripletail Wealth Management's GSK position peaked at $632K in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Tripletail Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.